A randomized trial, meta-analysis, and six independent studies consistently demonstrate that early detection with L-Dex and intervention reduces progression to chronic cancer-related lymphedema.
Discover advanced educational opportunities. Register for an upcoming event or access our past events.
Tracking changes in body composition – fluid, muscle, or fat – provides clinicians insight into disease progression and the ability to optimize treatment plans for success. Actionable data can also motivate patient compliance. Utilizing the SOZO® Digital Health Platform in your clinical practice can greatly improve outcomes and the quality of life for patients.1
Tape measurements are rudimentary and unreliable and cannot distinguish between fluid and tissue gain. SOZO measures and tracks critical patient data.
Detecting changes in body composition ensures your patients are losing or gaining weight the right way and helps establish healthy targets.
SOZO’s powerful data to aide in the assessment and management of chronic disease delivers:
Offer your patients peace of mind.
The L-Dex score, only available from ImpediMed, is designed to detect lymphedema-related fluid changes in the limbs.
The Lymphedema Prevention Program (LPP) is a comprehensive program for early detection and intervention of cancer-related lymphedema.
Empower your patients to change habits and take charge of their health.
BodyComp Analysis provides a complete fluid, tissue, and metabolic analysis of the human body.
Inspire your patients to care for their whole self.
Segmental BodyComp Analysis provides a detailed analysis of each arm and each leg.
Final 3-Year Primary Endpoint Results Published
NCCN Guidelines® recommend patient education and regular monitoring for the early detection of lymphedema.
Additional guidelines support early detection and intervention